Emicizumab for the prevention of bleeds in hemophilia A

Mahlangu, J

Mahlangu, J (reprint author), Univ Witwatersrand, Haematol, Johannesburg, South Africa.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2019; 19 (8): 753

Abstract

Introduction: The management of hemophilia A with and without inhibitors is challenging with high treatment burden of prophylactic regimens, musculosk......

Full Text Link